BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 21, 2015
View Archived Issues
New antibiotic effective against Gram-positive bacteria without detectable resistance
Read More
CEO presents development activity at BioMarin Pharmaceutical
Read More
New data on the effect of PennVax-B in HIV-1-infected adults
Read More
Vonapanitase induces vasodilatation in human atherosclerotic arteries
Read More
Depomed to acquire U.S. rights to NuCynta franchise
Read More
Merck Sharp & Dohme to study MK-8291 in patients with post-herpetic neuralgia with allodynia
Read More
Regado Biosciences and Tobira Therapeutics to create NASH company
Read More
Researchers present data on the diagnostic utility of [11C]PBB-3-based PET imaging
Read More
Active Biotech discusses pipeline outlook
Read More
DT-01 enhances HCC treatment antitumor activity in animal models
Read More
New phase II data for mipsagargin reported
Read More
Novel NS5B inhibitors disclosed by Merck & Co. for HCV
Read More
AbbVie divulges novel BTK inhibitors
Read More
Merck KGaA patents novel FSH-R modulators for infertility
Read More
Pfizer discloses new dopamine D1 receptor ligands
Read More
Forendo Pharma presents novel 17beta-HSD1 inhibitors
Read More
European Commission approves Novartis' Cosentyx in plaque psoriasis
Read More
Addex and Dystonia Medical Research Foundation to explore dipraglurant for dystonia
Read More
FDA grants fast track designation to deflazacort for Duchenne muscular dystrophy
Read More
FDA removes partial clinical hold on aldoxorubicin trials
Read More
Invion reports interim data from phase II trial of oral INV-102 in smoking cessation
Read More
Richter and Actavis report phase III results for cariprazine in schizophrenia
Read More
Oncore Biopharma merges with Tekmira Pharmaceuticals
Read More
BeiGene reports development of kinase inhibitors for cancer
Read More
Janssen researchers prepare TLR7 agonists
Read More
Laboratoire Biodim tests novel agents for HIV
Read More
Tiziana Life Sciences licenses milciclib from Nerviano Medical Sciences
Read More
Tobira initiates phase I study of cenicriviroc and pioglitazone
Read More
Verastem's VS-5584 awarded European orphan drug designation, begins new trial
Read More
BioInvent's BI-1206 to enter collaborative phase I/II trial
Read More
Qu Biologics initiates phase IIa trial of QBKPN SSI in NSCLC
Read More
Hybrigenics initiates phase II study of inecalcitol for CML
Read More
Eleison and Intelgen partner on Chinese development of inhaled lipid-complexed cisplatin
Read More